Novartis Pharma GmbH secures contract for Pharmaceutical products - drug discount agreement in accordance with Section 130c Paragraph 1 SGB V i V m Section 130a Paragraph 8 SGB V for the active ingredient erenumab

Germany, Aug. 31 -- Germany based Novartis Pharma GmbH has secured contract from AOK Baden-Wurttemberg for Pharmaceutical products - drug discount agreement in accordance with Section 130c Paragraph 1 SGB V i V m Section 130a Paragraph 8 SGB V for the active ingredient erenumab . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....